flibanserin

Flibanserin is used for hypoactive sexual desire disorder among women. It is sold under the trade name Addyi. It was originally developed as an antidepressant medication by Boehringer Ingelheim, but showed lack of efficacy in trials and was further developed as a hypoactive sexual disorder drug by Sprout Pharmaceuticals. Reference standards of Flibanserin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Flibanserin - API Standards 
    [catalogue_number] => PA 33 09000
    [category_ids] => ,89,80,79,
    [chemical_name] => 
    [weight] => 390.40
    [form] => C20H21F3N4O
    [cas] => 167933-07-5
    [pslug] => 167933-07-5-flibanserin-api-pa3309000
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 8
    [offers_name] => Ready Stock
    [offers_status] => 1
    [offers_start_date] => 2024-12-16
    [offers_end_date] => 2024-12-31
    [pageview] => 2
    [offers_slug] => ready-stock
    [offers_product_id] => 48185
    [offers_product_code] => PA 33 09000
    [offers_master_id] => 8
    [offer_percentage] => 20 % OFF
    [offers_product_main_cat] => Pharmaceutical Reference Standards
)